Vaccine Conjugate Market Report

Global Vaccine Conjugate Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 10, 2022
  • PAGES：177
  • REPORT CODE：GMM806545
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Vaccine Conjugate market report explains the definition, types, applications, major countries, and major players of the Vaccine Conjugate market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Sinovac Biotech Ltd

    • GlaxoSmithKline plc

    • Fablife

    • Pfizer

    • SutroVax Inc

    • Merck & Co, Inc

    • Sanofi Pasteur SA

    By Type:

    • Monovalent

    • Multivalent

    • Others

    By End-User:

    • Influenza

    • Meningococcal

    • Pneumococcal

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Vaccine Conjugate Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Vaccine Conjugate Outlook to 2028- Original Forecasts

    • 2.2 Vaccine Conjugate Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Vaccine Conjugate Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Vaccine Conjugate Market- Recent Developments

    • 6.1 Vaccine Conjugate Market News and Developments

    • 6.2 Vaccine Conjugate Market Deals Landscape

    7 Vaccine Conjugate Raw Materials and Cost Structure Analysis

    • 7.1 Vaccine Conjugate Key Raw Materials

    • 7.2 Vaccine Conjugate Price Trend of Key Raw Materials

    • 7.3 Vaccine Conjugate Key Suppliers of Raw Materials

    • 7.4 Vaccine Conjugate Market Concentration Rate of Raw Materials

    • 7.5 Vaccine Conjugate Cost Structure Analysis

      • 7.5.1 Vaccine Conjugate Raw Materials Analysis

      • 7.5.2 Vaccine Conjugate Labor Cost Analysis

      • 7.5.3 Vaccine Conjugate Manufacturing Expenses Analysis

    8 Global Vaccine Conjugate Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Vaccine Conjugate Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Vaccine Conjugate Export by Region (Top 10 Countries) (2017-2028)

    9 Global Vaccine Conjugate Market Outlook by Types and Applications to 2022

    • 9.1 Global Vaccine Conjugate Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Monovalent Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Multivalent Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Vaccine Conjugate Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Influenza Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Meningococcal Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Pneumococcal Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Vaccine Conjugate Market Analysis and Outlook till 2022

    • 10.1 Global Vaccine Conjugate Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Vaccine Conjugate Consumption (2017-2022)

      • 10.2.2 Canada Vaccine Conjugate Consumption (2017-2022)

      • 10.2.3 Mexico Vaccine Conjugate Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Vaccine Conjugate Consumption (2017-2022)

      • 10.3.2 UK Vaccine Conjugate Consumption (2017-2022)

      • 10.3.3 Spain Vaccine Conjugate Consumption (2017-2022)

      • 10.3.4 Belgium Vaccine Conjugate Consumption (2017-2022)

      • 10.3.5 France Vaccine Conjugate Consumption (2017-2022)

      • 10.3.6 Italy Vaccine Conjugate Consumption (2017-2022)

      • 10.3.7 Denmark Vaccine Conjugate Consumption (2017-2022)

      • 10.3.8 Finland Vaccine Conjugate Consumption (2017-2022)

      • 10.3.9 Norway Vaccine Conjugate Consumption (2017-2022)

      • 10.3.10 Sweden Vaccine Conjugate Consumption (2017-2022)

      • 10.3.11 Poland Vaccine Conjugate Consumption (2017-2022)

      • 10.3.12 Russia Vaccine Conjugate Consumption (2017-2022)

      • 10.3.13 Turkey Vaccine Conjugate Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Vaccine Conjugate Consumption (2017-2022)

      • 10.4.2 Japan Vaccine Conjugate Consumption (2017-2022)

      • 10.4.3 India Vaccine Conjugate Consumption (2017-2022)

      • 10.4.4 South Korea Vaccine Conjugate Consumption (2017-2022)

      • 10.4.5 Pakistan Vaccine Conjugate Consumption (2017-2022)

      • 10.4.6 Bangladesh Vaccine Conjugate Consumption (2017-2022)

      • 10.4.7 Indonesia Vaccine Conjugate Consumption (2017-2022)

      • 10.4.8 Thailand Vaccine Conjugate Consumption (2017-2022)

      • 10.4.9 Singapore Vaccine Conjugate Consumption (2017-2022)

      • 10.4.10 Malaysia Vaccine Conjugate Consumption (2017-2022)

      • 10.4.11 Philippines Vaccine Conjugate Consumption (2017-2022)

      • 10.4.12 Vietnam Vaccine Conjugate Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Vaccine Conjugate Consumption (2017-2022)

      • 10.5.2 Colombia Vaccine Conjugate Consumption (2017-2022)

      • 10.5.3 Chile Vaccine Conjugate Consumption (2017-2022)

      • 10.5.4 Argentina Vaccine Conjugate Consumption (2017-2022)

      • 10.5.5 Venezuela Vaccine Conjugate Consumption (2017-2022)

      • 10.5.6 Peru Vaccine Conjugate Consumption (2017-2022)

      • 10.5.7 Puerto Rico Vaccine Conjugate Consumption (2017-2022)

      • 10.5.8 Ecuador Vaccine Conjugate Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Vaccine Conjugate Consumption (2017-2022)

      • 10.6.2 Kuwait Vaccine Conjugate Consumption (2017-2022)

      • 10.6.3 Oman Vaccine Conjugate Consumption (2017-2022)

      • 10.6.4 Qatar Vaccine Conjugate Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Vaccine Conjugate Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Vaccine Conjugate Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Vaccine Conjugate Consumption (2017-2022)

      • 10.7.2 South Africa Vaccine Conjugate Consumption (2017-2022)

      • 10.7.3 Egypt Vaccine Conjugate Consumption (2017-2022)

      • 10.7.4 Algeria Vaccine Conjugate Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Vaccine Conjugate Consumption (2017-2022)

      • 10.8.2 New Zealand Vaccine Conjugate Consumption (2017-2022)

    11 Global Vaccine Conjugate Competitive Analysis

    • 11.1 Sinovac Biotech Ltd

      • 11.1.1 Sinovac Biotech Ltd Company Details

      • 11.1.2 Sinovac Biotech Ltd Vaccine Conjugate Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Sinovac Biotech Ltd Vaccine Conjugate Main Business and Markets Served

      • 11.1.4 Sinovac Biotech Ltd Vaccine Conjugate Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 GlaxoSmithKline plc

      • 11.2.1 GlaxoSmithKline plc Company Details

      • 11.2.2 GlaxoSmithKline plc Vaccine Conjugate Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 GlaxoSmithKline plc Vaccine Conjugate Main Business and Markets Served

      • 11.2.4 GlaxoSmithKline plc Vaccine Conjugate Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Fablife

      • 11.3.1 Fablife Company Details

      • 11.3.2 Fablife Vaccine Conjugate Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Fablife Vaccine Conjugate Main Business and Markets Served

      • 11.3.4 Fablife Vaccine Conjugate Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Pfizer

      • 11.4.1 Pfizer Company Details

      • 11.4.2 Pfizer Vaccine Conjugate Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Pfizer Vaccine Conjugate Main Business and Markets Served

      • 11.4.4 Pfizer Vaccine Conjugate Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 SutroVax Inc

      • 11.5.1 SutroVax Inc Company Details

      • 11.5.2 SutroVax Inc Vaccine Conjugate Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 SutroVax Inc Vaccine Conjugate Main Business and Markets Served

      • 11.5.4 SutroVax Inc Vaccine Conjugate Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Merck & Co, Inc

      • 11.6.1 Merck & Co, Inc Company Details

      • 11.6.2 Merck & Co, Inc Vaccine Conjugate Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Merck & Co, Inc Vaccine Conjugate Main Business and Markets Served

      • 11.6.4 Merck & Co, Inc Vaccine Conjugate Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Sanofi Pasteur SA

      • 11.7.1 Sanofi Pasteur SA Company Details

      • 11.7.2 Sanofi Pasteur SA Vaccine Conjugate Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Sanofi Pasteur SA Vaccine Conjugate Main Business and Markets Served

      • 11.7.4 Sanofi Pasteur SA Vaccine Conjugate Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    12 Global Vaccine Conjugate Market Outlook by Types and Applications to 2028

    • 12.1 Global Vaccine Conjugate Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Monovalent Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Multivalent Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Vaccine Conjugate Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Influenza Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Meningococcal Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Pneumococcal Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Vaccine Conjugate Market Analysis and Outlook to 2028

    • 13.1 Global Vaccine Conjugate Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.2.2 Canada Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Vaccine Conjugate Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.3.2 UK Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.3.3 Spain Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.3.5 France Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.3.6 Italy Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.3.8 Finland Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.3.9 Norway Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.3.11 Poland Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.3.12 Russia Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Vaccine Conjugate Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.4.2 Japan Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.4.3 India Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Vaccine Conjugate Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.5.3 Chile Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.5.6 Peru Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Vaccine Conjugate Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.6.3 Oman Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Vaccine Conjugate Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Vaccine Conjugate Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Vaccine Conjugate Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Vaccine Conjugate Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Vaccine Conjugate

    • Figure of Vaccine Conjugate Picture

    • Table Global Vaccine Conjugate Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Vaccine Conjugate Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Monovalent Consumption and Growth Rate (2017-2022)

    • Figure Global Multivalent Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Influenza Consumption and Growth Rate (2017-2022)

    • Figure Global Meningococcal Consumption and Growth Rate (2017-2022)

    • Figure Global Pneumococcal Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Vaccine Conjugate Consumption by Country (2017-2022)

    • Table North America Vaccine Conjugate Consumption by Country (2017-2022)

    • Figure United States Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Canada Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Mexico Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Table Europe Vaccine Conjugate Consumption by Country (2017-2022)

    • Figure Germany Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure UK Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Spain Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Belgium Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure France Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Italy Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Denmark Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Finland Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Norway Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Sweden Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Poland Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Russia Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Turkey Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Table APAC Vaccine Conjugate Consumption by Country (2017-2022)

    • Figure China Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Japan Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure India Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure South Korea Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Thailand Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Singapore Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Philippines Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Table South America Vaccine Conjugate Consumption by Country (2017-2022)

    • Figure Brazil Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Colombia Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Chile Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Argentina Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Peru Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Table GCC Vaccine Conjugate Consumption by Country (2017-2022)

    • Figure Bahrain Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Oman Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Qatar Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Table Africa Vaccine Conjugate Consumption by Country (2017-2022)

    • Figure Nigeria Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure South Africa Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Egypt Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure Algeria Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Table Oceania Vaccine Conjugate Consumption by Country (2017-2022)

    • Figure Australia Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Vaccine Conjugate Consumption and Growth Rate (2017-2022)

    • Table Sinovac Biotech Ltd Company Details

    • Table Sinovac Biotech Ltd Vaccine Conjugate Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sinovac Biotech Ltd Vaccine Conjugate Main Business and Markets Served

    • Table Sinovac Biotech Ltd Vaccine Conjugate Product Portfolio

    • Table GlaxoSmithKline plc Company Details

    • Table GlaxoSmithKline plc Vaccine Conjugate Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline plc Vaccine Conjugate Main Business and Markets Served

    • Table GlaxoSmithKline plc Vaccine Conjugate Product Portfolio

    • Table Fablife Company Details

    • Table Fablife Vaccine Conjugate Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fablife Vaccine Conjugate Main Business and Markets Served

    • Table Fablife Vaccine Conjugate Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Vaccine Conjugate Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Vaccine Conjugate Main Business and Markets Served

    • Table Pfizer Vaccine Conjugate Product Portfolio

    • Table SutroVax Inc Company Details

    • Table SutroVax Inc Vaccine Conjugate Sales, Price, Value and Gross Profit (2017-2022)

    • Table SutroVax Inc Vaccine Conjugate Main Business and Markets Served

    • Table SutroVax Inc Vaccine Conjugate Product Portfolio

    • Table Merck & Co, Inc Company Details

    • Table Merck & Co, Inc Vaccine Conjugate Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co, Inc Vaccine Conjugate Main Business and Markets Served

    • Table Merck & Co, Inc Vaccine Conjugate Product Portfolio

    • Table Sanofi Pasteur SA Company Details

    • Table Sanofi Pasteur SA Vaccine Conjugate Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur SA Vaccine Conjugate Main Business and Markets Served

    • Table Sanofi Pasteur SA Vaccine Conjugate Product Portfolio

    • Figure Global Monovalent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Multivalent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Influenza Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Meningococcal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pneumococcal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vaccine Conjugate Consumption Forecast by Country (2022-2028)

    • Table North America Vaccine Conjugate Consumption Forecast by Country (2022-2028)

    • Figure United States Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Vaccine Conjugate Consumption Forecast by Country (2022-2028)

    • Figure Germany Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Vaccine Conjugate Consumption Forecast by Country (2022-2028)

    • Figure China Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Vaccine Conjugate Consumption Forecast by Country (2022-2028)

    • Figure Brazil Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Vaccine Conjugate Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Vaccine Conjugate Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Vaccine Conjugate Consumption Forecast by Country (2022-2028)

    • Figure Australia Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Vaccine Conjugate Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US